Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;25(2):67-82.
doi: 10.1055/s-0032-1313777.

Identification of patients at risk for hereditary colorectal cancer

Affiliations

Identification of patients at risk for hereditary colorectal cancer

Nitin Mishra et al. Clin Colon Rectal Surg. 2012 Jun.

Abstract

Diagnosis of hereditary colorectal cancer syndromes requires clinical suspicion and knowledge of such syndromes. Lynch syndrome is the most common cause of hereditary colorectal cancer. Other less common causes include familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome (PJS), juvenile polyposis syndrome, and others. There have been a growing number of clinical and molecular tools used to screen and test at risk individuals. Screening tools include diagnostic clinical criteria, family history, genetic prediction models, and tumor testing. Patients who are high risk based on screening should be referred for genetic testing.

Keywords: Lynch syndrome; Peutz-Jeghers syndrome; familial adenomatous polyposis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Family history gathering directed at identifying patients at high risk for a colorectal cancer predisposition syndrome. From: Gammon A, Kohlmann W, Burt R. Can we identify the high-risk patients to be screened? A genetic approach. Digestion 2007;76(1):7–19. Copyright: S. Karger AG, Basel, Switzerland.
Figure 2
Figure 2
Algorithm for genetic evaluation of individuals with colorectal cancer based on revised Bethesda guidelines and PREMM score. IHC, immunohistochemistry; MSI, microsatellite instability.*Other models may be used. Each model has its own prespecified cutoff (PREMM1,2: http://www.dana-farber.org/pat/cancer/gastrointestinal/crc-calculator/default.asp; Barnetson: https://hnpccpredict.hgu.mrc.ac.uk/; MMR pro: http://astor.som.jhmi.edu/Bayes-Mendel/). If loss of MLH1 expression, BRAF analysis should be performed. Surveillance recommendations based on personal and family history. From Grover S, Syngal S. Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroentrol 2009; 23:185–196. Reprinted with kind permission of Elsevier.

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–249. - PubMed
    1. Mecklin J P. Frequency of hereditary colorectal carcinoma. Gastroenterology. 1987;93(5):1021–1025. - PubMed
    1. Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res. 1989;49(15):4344–4348. - PubMed
    1. Jasperson K W, Tuohy T M, Neklason D W, Burt R W. Hereditary and familial colon cancer. Gastroenterology. 2010;138(6):2044–2058. - PMC - PubMed
    1. Samowitz W S, Curtin K, Lin H H. et al.The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology. 2001;121(4):830–838. - PubMed